Literature DB >> 678047

Abnormalities of cerebral lateralization in schizophrenia patients.

L Schweitzer, E Becker, H Welsh.   

Abstract

Initial lateral eye movements (LEMs) have been shown to be associated with activation of the contralateral frontal lobes. Using LEM as a criterion measure of activation, schizophrenics were compared to normals with respect to the processing of four types of stimuli: verbal nonemotional (VNE), verbal emotional (VE), spatial nonemotional (SNE), and spatial emotional (SE). Our results indicate that schizophrenics initiate thought in their left hemisphere significantly more often than controls when one compares all test conditions and on VNE, VE, and SE material. Neither medication nor level of education had an appreciable effect on LEM in either group. However, sex was a significant variable; women irrespective of diagnosis consistently used the left hemisphere more often than men. The inappropriate initiation of thought on SE material as well as the overall increase in left hemisphere activity suggest left hemisphere disorder. This is consistent with other findings that suggest a left hemisphere locus of disturbance in schizophrenia.

Entities:  

Mesh:

Year:  1978        PMID: 678047     DOI: 10.1001/archpsyc.1978.01770320076006

Source DB:  PubMed          Journal:  Arch Gen Psychiatry        ISSN: 0003-990X


  3 in total

1.  Left hemisphere hyperactivity in schizophrenia: abnormality inherent to psychosis or neuroleptic side-effects?

Authors:  R Tomer; M Mintz; M S Myslobodsky
Journal:  Psychopharmacology (Berl)       Date:  1982       Impact factor: 4.530

2.  Telemetered EEG in schizophrenia: spectral analysis during abnormal behaviour episodes.

Authors:  J R Stevens; A Livermore
Journal:  J Neurol Neurosurg Psychiatry       Date:  1982-05       Impact factor: 10.154

3.  Eye movement research with schizophrenic patients and normal controls using corneal reflection-pupil center measurement.

Authors:  W Gaebel; G Ulrich; K Frick
Journal:  Eur Arch Psychiatry Neurol Sci       Date:  1986
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.